AbbVie (ABBV) Goodwill & Intangibles (2012 - 2026)

AbbVie (ABBV) reported Goodwill & Intangibles of $86.4 billion for Q1 2026, down 7.82% year-over-year from $93.8 billion in Q1 2025, and down 2.08% quarter-over-quarter from $88.3 billion in Q4 2025.

AbbVie (ABBV) Goodwill & Intangibles (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has 15 years of Goodwill & Intangibles data on file, last reported at $86.4 billion in Q1 2026.

  • Goodwill & Intangibles for Q1 2026 came in at $86.4 billion, down 7.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $86.4 billion (down 7.82% YoY), and the FY2025 annual result was $88.3 billion, down 7.1% from the prior year.
  • Goodwill & Intangibles fell to $86.4 billion in Q1 2026 per ABBV's latest filing, from $88.3 billion in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $106.3 billion in Q1 2022 and troughed at $36.3 billion in Q3 2025.
  • A 5-year average of $92.0 billion and a median of $95.0 billion in 2024 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles grew 12.4% in 2024, then slumped 64.35% in 2025.
  • A 5-year view of Goodwill & Intangibles shows it stood at $99.6 billion in 2022, then slipped by 11.74% to $87.9 billion in 2023, then rose by 8.1% to $95.0 billion in 2024, then slipped by 7.1% to $88.3 billion in 2025, then declined by 2.08% to $86.4 billion in 2026.
  • Business Quant data shows ABBV's Goodwill & Intangibles at $86.4 billion in Q1 2026, $88.3 billion in Q4 2025, and $36.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 86.44 Bn
Dec 31, 2025 88.28 Bn
Sep 30, 2025 36.34 Bn
Jun 30, 2025 92.67 Bn
Mar 31, 2025 93.77 Bn
Dec 31, 2024 95.02 Bn
Sep 30, 2024 101.94 Bn
Jun 30, 2024 93.63 Bn
Mar 31, 2024 95.65 Bn
Dec 31, 2023 87.90 Bn
Sep 30, 2023 90.69 Bn
Jun 30, 2023 95.09 Bn
Mar 31, 2023 97.07 Bn
Dec 31, 2022 99.60 Bn
Sep 30, 2022 100.45 Bn
Jun 30, 2022 103.85 Bn
Mar 31, 2022 106.28 Bn
Dec 31, 2021 108.33 Bn
Sep 30, 2021 109.75 Bn
Jun 30, 2021 111.74 Bn